Search
Sign In
Sign In
Sources
6 Total Sources
Merck Lifts 2026 Sales Outlook to $67.3 Billion as Winrevair Demand Offsets Profit Hit
Left
60%
Right
40%
All
6
Left
3
Right
2
Others
1
Bloomberg
1d ago
Merck Lifts 2026 Sales Outlook to $67.3 Billion on Strong Drug Demand
The Wall Street Journal
1d ago
Merck Cuts Full-Year Profit Forecast as Acquisition Costs Weigh on Bottom Line - WSJ
CNBC
1d ago
Merck Cuts 2026 Profit Guidance Due to $14.7 Billion Acquisition Charges for Terns and Cidara
The Globe and Mail
1d ago
Merck's sales rise more than expected, lifts full-year outlook - The Globe and Mail
Merck
1d ago
Merck Reports Q2 2026 Sales of $16.6B, $0.54 GAAP Loss Per Share; Highlights Regulatory Milestones
Quartz
1d ago
Merck Cuts 2026 Profit Forecast Citing Acquisition Charges